Jove
Visualize
Contact Us

Related Experiment Videos

Platelet factor 4 binding to glomerular microvascular matrix.

V Y Wu, M P Cohen

    Biochimica Et Biophysica Acta
    |January 24, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Analysis of factor VIII gene inversion mutations in 166 unrelated haemophilia A families: frequency and utility in genetic counselling.

    Haemophilia : the official journal of the World Federation of Hemophilia·2016
    Same author

    Expansion of genetic services utilizing a general genetic counseling clinic.

    Journal of genetic counseling·2013
    Same author

    Increased urinary type IV collagen marks the development of glomerular pathology in diabetic d/db mice.

    Metabolism: clinical and experimental·2001
    Same author

    Measuring glycated proteins: clinical and methodological aspects.

    Diabetes technology & therapeutics·2001
    Same author

    Serum type IV collagen in diabetic patients at risk for nephropathy.

    Diabetes care·2001
    Same author

    Identification of calnexin as a binding protein for Amadori-modified glycated albumin.

    Biochemical and biophysical research communications·2001
    Same journal

    Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Molecular Basis of Disease Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    General Subjects Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

    Biochimica et biophysica acta·2019
    Same journal

    Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

    Biochimica et biophysica acta·2019
    Same journal

    Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

    Biochimica et biophysica acta·2019
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Platelet factor 4 binds to kidney glycosaminoglycans, particularly heparan sulfate in the glomerular basement membrane. Diabetes reduces these binding sites, suggesting Platelet factor 4

    Area of Science:

    • Biochemistry
    • Nephrology
    • Pathology

    Background:

    • Platelet factor 4 (PF4) is released during platelet aggregation.
    • Sulfated glycosaminoglycans (GAGs) are present in the renal cortex.
    • Alterations in glomerular basement membrane (GBM) are observed in diabetes.

    Purpose of the Study:

    • To investigate the binding of Platelet factor 4 (PF4) to renal sulfated glycosaminoglycans (GAGs).
    • To determine if PF4 binding to glomerular GAGs is altered in diabetes.
    • To explore the role of PF4 in diabetic nephropathy.

    Main Methods:

    • Electrophoretic mobility assays to demonstrate PF4-GAG binding.
    • Enzymatic digestion (hyaluronidase, chondroitinase ABC) and nitrous acid treatment of GAGs.

    Related Experiment Videos

  • Incubation of radiolabeled PF4 with isolated rat glomeruli and human/rat GBM.
  • Displacement assays using heparin to quantify PF4 binding to heparan sulfate anionic sites.

    • Main Results:

    • PF4 binds to sulfated GAGs from human renal cortex, with binding dependent on pH and ionic strength.
    • Binding is preserved after hyaluronidase and chondroitinase digestion, indicating interaction with heparan sulfate.
    • PF4 binding to glomerular GBM is decreased in diabetic patients and experimental diabetes models.
    • Heparan sulfate anionic sites in GBM are diminished in diabetes.

    Conclusions:

    • Platelet factor 4 interacts with heparan sulfate anionic sites in the glomerular microvascular matrix.
    • Diminished heparan sulfate in diabetic GBM reduces PF4 binding.
    • These findings suggest PF4's involvement in altered capillary integrity in diabetes and highlight reduced GAGs in diabetic nephropathy.